Drug Repurposing and Lysosomal Storage Disorders - Genes - X-MOL
... lysosomal storage disorders (LSDs), a cluster of rare metabolic diseases ... Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat
Article Versions Notes - MDPI
Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat. Genes ... Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat. Genes. 2024 ...
TV Series on DVD
Old Hard to Find TV Series on DVD
Drug Repurposing and Lysosomal Storage Disorders: A Trick ... - IRIS
Our review systematically explores the landscape of drug repositioning as a means to enhance LSDs therapies. The findings advocate for the strategic ...
Drug-induced phospholipidosis confounds drug repurposing ... - NCBI
Repurposing drugs as treatments for COVID-19, the disease ... Drug induced phospholipidosis: An acquired lysosomal storage disorder. ... drugs for treatment of ...
Treatment strategies for lysosomal storage disorders - Beck
For a few lysosomal storage disorders, new therapies are available or under development. ยท These therapies include enzyme replacement therapy, ...
Lysosomes as a therapeutic target | Nature Reviews Drug Discovery
It should be noted that therapeutic approaches to treat inflammatory and autoimmune diseases aim to inhibit the deleterious excessive lysosomal ...
DRUG INDUCED PHOSPHOLIPIDOSIS: AN ACQUIRED ... - NCBI
There is a strong association between lysosome enzyme deficiencies and monogenic disorders resulting in lysosomal storage disease.
Drug repositioning and polypharmacology. A drug can have more ...
Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat. Article ... drug reactions related to common medications used to treat Parkinson's disease.
Drug repurposing for rare: progress and opportunities for ... - Frontiers
Repurposing is one of the key opportunities to address the unmet rare diseases therapeutic need. Based on cases of drug repurposing in small ...